Site Editors

Shaji K. Kumar, MD

Prashant Kapoor, MD, FACP


Ajay K. Nooka, MBBS, on Maintenance Therapy: Benefits Reported in High-Risk Myeloma

Posted: Thursday, September 21, 2023

Ajay K. Nooka, MBBS, of Winship Cancer Center of Emory University, discusses phase II findings showing benefits for patients with high-risk myeloma who were given carfilzomib, pomalidomide, and dexamethasone as maintenance therapy. Dr. Nooka reviews the clinical considerations of this regimen.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.